Announce Date | 05/02/2024 |
EPS Normalized Actual | $4.57 (Miss by $-0.43) |
EPS GAAP Actual | $4.57 (Miss by $-0.43) |
Revenue Actual | $1.644B |
Revenue Surprise | Beat by $1644M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $5.72247 |
EPS GAAP Estimate | $5.72247 |
Revenue Estimate | $5.4183858B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 21.745 | 12.4 | 17.17467 | 33.21652 | 3 |
Dec 2027 | 20.455 | 13.18 | 16.1558 | 31.24598 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2024 (Mar 2024) | 4.68 | 4.68 | 1.644B | -179.62% | 1644M |
FQ4 2023 (Dec 2023) | 0 | 0 | 5.076B | 100% | 5076M |
FQ3 2023 (Sep 2023) | 5.58 | 5.58 | 1.733B | 100% | 1733M |
FQ2 2023 (Jun 2023) | 4.71 | 4.71 | 1.626B | 100% | 1626M |
FQ1 2023 (Mar 2023) | 5.19 | 5.19 | 4.597B | 100% | 4597M |
FQ4 2022 (Dec 2022) | 6.17 | 6.17 | 0B | NAN% | 0M |
FQ3 2022 (Sep 2022) | 8.3 | 8.3 | 0B | NAN% | 0M |
FQ2 2022 (Jun 2022) | 9.8 | 9.8 | 0B | NAN% | 0M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
5.72247
Consensus Revenue Estimates
5.4183858B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 6.09104 | -- | 4.6808 | 8.30935 | 9 |
FQ3 2026 (Jul 2026) | 5.95444 | -- | 4.57583 | 8.123 | 9 |
FQ2 2026 (Jun 2026) | 6.00864 | -- | 4.59397 | 9.15289 | 4 |
FQ1 2026 (Mar 2026) | 6.01963 | -- | 4.60237 | 9.16963 | 4 |
FQ4 2025 (Oct 2025) | 5.90201 | -- | 4.53554 | 8.05148 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 5.4B | -- | 4.44B | 6.92B | 4 |
FQ3 2026 (Jul 2026) | 5.34B | -- | 4.39B | 6.84B | 4 |
FQ2 2026 (Jun 2026) | 17.77B | -- | 14.55B | 24.92B | 4 |
FQ1 2026 (Mar 2026) | 16.5B | -- | 13.51B | 23.14B | 7 |
FQ4 2025 (Oct 2025) | 5.48B | -- | 4.51B | 7.02B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
5
Revenue # of Misses
0
Revenue # of in-lines
3
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2024 (Mar 2024) | 4.68 | 4.68 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 5.58 | 5.58 | 100% | |
FQ2 2023 (Jun 2023) | 4.71 | 4.71 | 100% | |
FQ1 2023 (Mar 2023) | 5.19 | 5.19 | 100% | |
FQ4 2022 (Dec 2022) | 6.17 | 6.17 | 100% | |
FQ3 2022 (Sep 2022) | 8.3 | 8.3 | 100% | |
FQ2 2022 (Jun 2022) | 9.8 | 9.8 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2024 (Mar 2024) | $0B | $1.64B | $1644M | 100% |
FQ4 2023 (Dec 2023) | $0B | $5.08B | $5076M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.73B | $1733M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.63B | $1626M | 100% |
FQ1 2023 (Mar 2023) | $0B | $4.6B | $4597M | 100% |
FQ4 2022 (Dec 2022) | $0B | $0B | $0M | NAN% |
FQ3 2022 (Sep 2022) | $0B | $0B | $0M | NAN% |
FQ2 2022 (Jun 2022) | $0B | $0B | $0M | NAN% |